Author:
Lesch Otto-Michael,Platz Werner E.,Soyka Michael,Walter Henriette
Reference73 articles.
1. Anthenelli R (2004) Smoking cessation in smokers motivated to quit. Presented at: American College of Cardiology Scientif c Sessions: March 7-10; New Orleans, LA
2. Benowitz Nl, Porchet H, Sheiner L et al. (1988) Nicotine absorption and cardiovascular ef ects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 44: 23–28
3. Cahill K, Stead LF, Lancaster T (2007) Nicotine receptor partial agonists for smoking cessation (Review). The Cochrane Library 1: 1–25
4. Coe JW, Brooks PR, Vetelino MG et al. (2005) Varenicline an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 48/10: 3474–7
5. Cohen C, Perrault G, Voltz C et al. (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing ef ects of nicotine in rats. Behav Pharmacol 13: 451–463